VITA LIFE SCIENCES LIMITED..
ASX:VLSPharmaceuticals, Biotechnology & Life SciencesToday’s holders own 96.4% of what they think they own, once every option and right converts.
No major dilution pressure signals in current disclosures
VITA LIFE SCIENCES LIMITED had 54M ordinary shares on issue as of October 2026, its latest share-count filing; the filed Appendix 2A series ends before the start of that window, so the percentage change in share count over the period is not stated. The company has not conducted any capital raisings in the past 24 months. Options and rights on issue could convert into 2M new shares, representing a 3.7% overhang of current shares; none are in the money, and the nearest expiry date is not stated in available filings. The latest cash report, a half-year document to June 2026, shows non-negative net cash flow, so no funding-runway figure applies. No proposed securities issues are pending.
Quick answers · 2
How much placement capacity does VLS have left?
None of the 15% placement capacity counted as used in the last 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.
How many options and rights does VLS have outstanding?
Unexercised options and rights equal 3.7% of Vita Life Sciences's shares on issue.
Shares on issue — last 2 years
Cumulative figures as stated by the company on its daily notice. Latest notice
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 8 Oct 2026 | 3H · cancellation | VLS : ORDINARY FULLY PAID | 53.9M | Appendix 3H |
| 16 Sept 2026 | 3H · cancellation | VLS : ORDINARY FULLY PAID | 54.1M | Appendix 3H |
| 7 Sept 2026 | 3H · cancellation | VLS : ORDINARY FULLY PAID | 54.1M | Appendix 3H |
| 1 Sept 2026 | 3H · cancellation | VLS : ORDINARY FULLY PAID | 54.1M | Appendix 3H |
| 2 July 2026 | 3H · cancellation | VLS : ORDINARY FULLY PAID | 54.4M | Appendix 3H |
Securities on issue over time
Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.
Capital raises
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
No option supply on record carries an exercise price to pay, so no share price switches any of it on. All 2.0M of it converts on something else — a hurdle that may never be met, or terms the filing does not price.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| VLSAD | Performance shares | Condition-triggered | — | — | 2.0M | Filing Meeting |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.
A condition-triggered class has no exercise price and usually no expiry: what it vests on is set by a shareholder resolution, not by the register. Where the company lodged a notice of meeting before the class first appears here, it is linked as “Meeting” — that is where terms of this kind are put to shareholders. It is not confirmation that the document sets this class’s conditions, and no link appears where there is no such filing.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 2 Oct 2026 | Peter Osborne | Buy on-market | 1k | — | — | — | 3Y notice |
| 1 Sept 2026 | Henry George Townsing | Sell off-market | — | — | — | — | 3Y notice |
| 9 June 2026 | Andrew O'Keefe | Other | 600k | — | — | $300k | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.